About PanTher Therapeutics
PanTher Therapeutics is a company based in Cambridge (United States) founded in 2014. It operates as a HealthTech. PanTher Therapeutics has raised $15.35 million across 10 funding rounds from investors including CHV, Angel Physicians Fund and state.tx.us. The company has 47 employees as of October 31, 2017. PanTher Therapeutics offers products and services including PTM-101 and Sagittari Platform. PanTher Therapeutics operates in a competitive market with competitors including Tonix Pharma, PolyPid, Onconic Therapeutics, Zyl Therapeutics and Santen Pharmaceuticals, among others.
- Headquarter Cambridge, United States
- Employees 47 as on 31 Oct, 2017
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Panther Therapeutics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.35 M (USD)
in 10 rounds
-
Latest Funding Round
$3.02 M (USD), Series B
Mar 14, 2025
-
Investors
CHV
& 2 more
-
Employee Count
47
as on Oct 31, 2017
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PanTher Therapeutics
PanTher Therapeutics offers a comprehensive portfolio of products and services, including PTM-101 and Sagittari Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A chemotherapy patch for pancreatic cancer treatment developed.
Platform for creating optimized cancer drug delivery systems.
Unlock access to complete
Unlock access to complete
Funding Insights of PanTher Therapeutics
PanTher Therapeutics has successfully raised a total of $15.35M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $3.02 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $3.0M
-
First Round
First Round
(08 Jun 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series B - PanTher Therapeutics | Valuation |
investors |
|
| Nov, 2023 | Amount | Series A - PanTher Therapeutics | Valuation |
investors |
|
| Dec, 2022 | Amount | Series A - PanTher Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PanTher Therapeutics
PanTher Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include CHV, Angel Physicians Fund and state.tx.us. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment and advisory services are provided to healthcare startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PanTher Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PanTher Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Panther Therapeutics Comparisons
Competitors of PanTher Therapeutics
PanTher Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tonix Pharma, PolyPid, Onconic Therapeutics, Zyl Therapeutics and Santen Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation medicines for CNS and immunological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and gastrointestinal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for ophthalmology and rheumatology diseases are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Panther Therapeutics
Frequently Asked Questions about PanTher Therapeutics
When was PanTher Therapeutics founded?
PanTher Therapeutics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is PanTher Therapeutics located?
PanTher Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is PanTher Therapeutics a funded company?
PanTher Therapeutics is a funded company, having raised a total of $15.35M across 10 funding rounds to date. The company's 1st funding round was a Series A of $1.26M, raised on Jun 08, 2015.
How many employees does PanTher Therapeutics have?
As of Oct 31, 2017, the latest employee count at PanTher Therapeutics is 47.
What does PanTher Therapeutics do?
PanTher Therapeutics is engaged in developing advanced cancer treatments through its proprietary Sagittari platform. The company specializes in long-lasting, high-dose local chemotherapeutic solutions for oncology, targeting tumors with minimal systemic exposure. Its lead product, PTM-101, is under clinical development for pancreatic cancer. The platform is utilized to engineer drug products for optimal dose and duration, integrated with interventional oncology procedures. Pipeline opportunities are also being explored to expand therapeutic applications in the healthcare sector.
Who are the top competitors of PanTher Therapeutics?
PanTher Therapeutics's top competitors include Tonix Pharma, PolyPid and Onconic Therapeutics.
What products or services does PanTher Therapeutics offer?
PanTher Therapeutics offers PTM-101 and Sagittari Platform.
Who are PanTher Therapeutics's investors?
PanTher Therapeutics has 3 investors. Key investors include CHV, Angel Physicians Fund, and state.tx.us.